Clinical Trial Supplies

Global Clinical Trial Supplies Market to Reach US$3.7 Billion by 2030

The global market for Clinical Trial Supplies estimated at US$2.7 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Phase I Clinical Trial Supplies, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$532.1 Million by the end of the analysis period. Growth in the Phase II Clinical Trial Supplies segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$728.4 Million While China is Forecast to Grow at 4.5% CAGR

The Clinical Trial Supplies market in the U.S. is estimated at US$728.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$587.4 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Clinical Trial Supplies Market - Key Trends & Drivers Summarized

What Makes Clinical Trial Supplies Critical to the Success of Clinical Research?

Clinical trial supplies are the backbone of any clinical study, as they ensure that drugs, medical devices, and related equipment reach trial sites on time, in appropriate quantities, and with assured quality. These supplies include investigational drugs, placebos, ancillary supplies, diagnostic kits, and personal protective equipment, all crucial for conducting safe and effective trials. An efficient supply chain for clinical trials is essential to avoid delays, maintain regulatory compliance, and reduce the risk of costly trial failures. Clinical trials, particularly Phase II and Phase III studies, often involve multiple sites across regions and countries, making supply logistics increasingly complex. Moreover, the highly sensitive nature of clinical supplies—such as temperature-controlled drugs and biologics—demands specialized packaging, transportation, and storage solutions to maintain product integrity. As trials expand to new regions and become decentralized, the management of clinical supplies has become even more intricate, requiring real-time tracking, effective inventory management, and strict adherence to Good Manufacturing Practices (GMP). This complex process highlights the importance of a well-coordinated clinical trial supply chain, as even minor supply disruptions can jeopardize trial results and delay the development of potentially life-saving treatments.

How Are Technological Innovations Transforming Clinical Trial Supply Management?

Technological advancements are revolutionizing the management of clinical trial supplies, enabling more efficient, transparent, and data-driven processes. The integration of digital tracking solutions, such as Radio Frequency Identification (RFID) and Internet of Things (IoT) sensors, allows real-time monitoring of supply shipments, providing visibility into conditions like temperature, humidity, and location. This is particularly crucial for sensitive investigational products, including biologics and personalized medicines, which require precise environmental conditions to retain efficacy. Additionally, cloud-based platforms and supply chain management software have streamlined inventory tracking and demand forecasting, allowing clinical trial sponsors to anticipate supply needs accurately and minimize wastage. The rise of automation in warehousing and packaging has also contributed to improved efficiency, reducing human error and ensuring that supplies are prepared and labeled accurately before distribution. Moreover, artificial intelligence (AI) and machine learning are increasingly being used to analyze data from previous trials, optimizing supply chain strategies and predicting potential risks. These technological innovations enhance the clinical supply chain’s reliability and flexibility, empowering researchers to respond more quickly to changes and challenges during trials.

How Are Trends Like Decentralized Trials and Personalized Medicine Impacting Clinical Trial Supplies?

The rise of decentralized trials and the expansion of personalized medicine are reshaping clinical trial supply needs and logistics. Decentralized clinical trials (DCTs), which involve remote monitoring and home-based care, have grown rapidly due to the need for patient-centric approaches and accelerated by the COVID-19 pandemic. DCTs require clinical supplies to be shipped directly to patients’ homes, necessitating more flexible packaging, reliable tracking, and faster delivery systems. This shift has increased the demand for direct-to-patient logistics, where patient confidentiality, regulatory compliance, and on-time delivery become even more challenging. Personalized medicine, especially in oncology and rare disease treatment, is also influencing the clinical supply chain by necessitating the production and shipment of patient-specific treatments. These therapies, often developed in smaller batches and with unique handling requirements, demand a highly customized supply chain to ensure that each dose reaches the right patient at the right time. The growing complexity and diversity of clinical trials are thus driving innovations in supply chain solutions, pushing companies to adapt to trends that prioritize patient convenience and meet the stringent demands of personalized therapies.

What’s Driving Growth in the Clinical Trial Supplies Market?

The growth in the clinical trial supplies market is driven by several factors, including the expansion of global clinical trials, advances in digital supply chain management, and the rising trend toward decentralized and personalized trials. The globalization of clinical trials, as sponsors seek diverse patient populations across regions, has heightened demand for robust supply chain solutions that can manage cross-border logistics and regulatory compliance. Advances in technology, such as real-time monitoring, AI-driven forecasting, and cloud-based inventory systems, have further supported market growth by making the clinical supply chain more adaptive and resilient. The shift toward decentralized trials has also increased demand for direct-to-patient logistics and specialized packaging, as supplies now need to be shipped to individual patients in addition to centralized sites. Additionally, the rise of personalized medicine has introduced unique challenges in supply management, necessitating precise control over production and delivery timelines to meet patient-specific requirements. Together, these trends underscore a strong growth trajectory for the clinical trial supplies market, driven by technological innovation, expanding applications, and evolving patient-centered trial designs that demand high adaptability and precision in supply chain logistics.

Select Competitors (Total 33 Featured) -
  • Almac Group
  • Bilcare Limited
  • Biocair
  • Capsugel (Part of Lonza Group)
  • Catalent, Inc.
  • CSM- Clingen Company
  • Eurofins Scientific
  • Infosys Limited
  • KLIFO A/S
  • Marken (A Subsidiary of UPS)
  • Metrics Contract Services
  • N-Side
  • O&M Movianto (Part of Owens & Minor)
  • Parexel International Corporation
  • PCI Services
  • PRA Health Sciences, Inc.
  • Seveillar Clinical Trial Supplies Pvt. Ltd.
  • SIRO Clinpharm Pvt. Ltd.
  • Thermo Fisher Scientific, Inc.
  • UDG Healthcare PLC.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Clinical Trial Supplies – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Complexity of Clinical Trials Drives Demand for Efficient and Reliable Clinical Trial Supply Management Solutions
Growing Number of Decentralized and Virtual Clinical Trials Expands Need for Direct-to-Patient Supply Logistics
Rising Emphasis on Supply Chain Transparency and Traceability Fuels Demand for Real-Time Clinical Trial Supply Solutions
Advancements in Temperature-Controlled Packaging Solutions Propel Demand for Clinical Supplies in Cold Chain Management
Growing Adoption of Personalized Medicine and Adaptive Trials Expands Market for Flexible and Customizable Supply Solutions
Increasing Use of Advanced Analytics and AI in Forecasting Trial Supply Needs Enhances Market Potential for Predictive Supply Solutions
Expansion of Clinical Trials in Emerging Markets Drives Demand for Localized Supply Solutions and Infrastructure
Rising Demand for Single-Use and Disposable Medical Supplies in Clinical Trials Expands Addressable Market for Supplies Providers
Growing Need for Efficient Inventory Management and Waste Reduction Drives Demand for Streamlined Supply Solutions
Enhanced Focus on Patient-Centric Supply Models to Support Direct-to-Patient Deliveries in Remote Trials
Increased Use of IoT and RFID Technologies in Clinical Trial Supplies Strengthens Inventory Monitoring and Tracking
Expansion of Biologics and Cell and Gene Therapy Trials Drives Demand for Specialized Clinical Trial Supplies
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Clinical Trial Supplies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Clinical Trial Supplies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Clinical Trial Supplies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Phase I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Phase I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Phase I by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Phase II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Phase II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Phase II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Phase III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Phase III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Phase III by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Clinical Trial Supplies Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 14: World Recent Past, Current & Future Analysis for Other Phases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Other Phases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Other Phases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Medical Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 35: Canada Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 47: China Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 53: Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Clinical Trial Supplies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Clinical Trial Supplies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 62: France Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 65: France Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 68: Germany Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 71: Germany Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 77: Italy Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 80: UK Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 83: UK Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Europe 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Asia-Pacific 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of World Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of World 16-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2014, 2024 & 2030
TABLE 101: Rest of World Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of World Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of World 16-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings